Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Margarita Sanchez Del Rio"'
Autor:
Simona Sacco, Christian Lampl, Antoinette Maassen van den Brink, Valeria Caponnetto, Mark Braschinsky, Anne Ducros, Patrick Little, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Paolo Martelletti, Zaza Katsarava, On behalf of the Burden and Attitude to Resistant and Refractory (BARR) Study Group
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background New treatments are currently offering new opportunities and challenges in clinical management and research in the migraine field. There is the need of homogenous criteria to identify candidates for treatment escalation as well as
Externí odkaz:
https://doaj.org/article/7f47e162ba404dc98e99802a6fd4a987
Autor:
Simona Sacco, Mark Braschinsky, Anne Ducros, Christian Lampl, Patrick Little, Antoinette Maassen van den Brink, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Zaza Katsarava, Paolo Martelletti
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Introduction Despite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief with acute and preventive treatments. It is the aim of the present document to provide a definition of
Externí odkaz:
https://doaj.org/article/dca6aaca5bc747218f38a0f90cf4db9a
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Lasmiditan, a highly selective 5-hydroxytryptamine receptor 1F (5-HT 1F ) agonist, is the first drug in its class and is lacking triptan-like vasoactive properties. The US Food and Drug Administration (FDA) has recently approved lasmiditan for the ac
Externí odkaz:
https://doaj.org/article/5b3d8f13d2ef4ebb89199d6283568b9e
Autor:
Christian Lampl, Antoinette MaassenVanDenBrink, Christina I. Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Margarita Sanchez-del-Rio, Uwe Reuter, Derya Uluduz, Jan Versijpt, Dena Zeraatkar, Simona Sacco
Publikováno v:
Journal of Headache and Pain, 24(1):56. Springer-Verlag Italia
Objective While there are several trials that support the efficacy of various drugs for migraine prophylaxis against placebo, there is limited evidence addressing the comparative safety and efficacy of these drugs. We conducted a systematic review an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41a67abee22047c7bf39448d368ac92
https://doi.org/10.1186/s10194-023-01594-1
https://doi.org/10.1186/s10194-023-01594-1
Autor:
Christian Lampl, Antoinette MaassenVanDenBrink, Faisal Mohammad Amin, Christina I Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Margarita Sanchez-del-Rio, Uwe Reuter, Derya Uluduz, Jan Versijpt, Dena Zeraatkar, Simona Sacco
Objective: While there are several trials that support the efficacy of various drugs for migraine prophylaxis against placebo, there is limited evidence addressing the comparative safety and efficacy of these drugs. We conducted a systematic review a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e7441c26babd449507db0aef3e5cd9
https://doi.org/10.21203/rs.3.rs-2789503/v1
https://doi.org/10.21203/rs.3.rs-2789503/v1
Autor:
Christian Lampl, Jan Versijpt, Christina Deligianni, Raquel Gil-Gouveia, Tanvir Jassal, Antoinette MaassenVanDenBrink, Raffaele Ornello, Jakob Paungarttner, Margarita Sanchez-del-Rio, Uwe Reuter, Derya Uluduz, Tessa de Vries, Dena Zeraatkar, Simona Sacco
Objective The aim of this paper is to critically re-appraise the published trials assessing amitriptyline for migraine prophylaxis. Methods We report our methods and results following the Preferred Reporting Items for Systematic Reviews (PRISMA), by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bc43e41710b63dcbfba041c90d12d0b
https://doi.org/10.21203/rs.3.rs-2673135/v1
https://doi.org/10.21203/rs.3.rs-2673135/v1
Autor:
J.M. Láinez, Rogelio Leira, Patricia Pozo-Rosich, Victor José Gallardo, Alicia Alpuente, Margarita Sanchez del Rio, Marta Torres-Ferrus, Jérôme Trochet, Xim Cerda-Company
Publikováno v:
Headache: The Journal of Head and Face Pain. 61:1403-1410
OBJECTIVE This internet survey aimed to analyze the activity of midolordecabeza.org, a specialized website for headache stakeholders. BACKGROUND eHealth tools, such as websites, can be educational for stakeholders of a specific disease, such as patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5702992837655b14fadda71d7515ac37
https://doi.org/10.1111/head.14225
https://doi.org/10.1111/head.14225
Autor:
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, Lars Bendtsen, Christina I. Deligianni, Raquel Gil-Gouveia, Zaza Katsarava, Antoinette MaassenVanDenBrink, Paolo Martelletti, Dimos-Dimitrios Mitsikostas, Raffaele Ornello, Uwe Reuter, Margarita Sanchez-del-Rio, Alexandra J. Sinclair, Gisela Terwindt, Derya Uluduz, Jan Versijpt, Christian Lampl
Publikováno v:
Journal of Headache and Pain, 23(1). BMC
Sacco, S, Amin, F M, Ashina, M, Bendtsen, L, Deligianni, C I, Gil-Gouveia, R, Katsarava, Z, MaassenVanDenBrink, A, Martelletti, P, Mitsikostas, D D, Ornello, R, Reuter, U, Sanchez-del-Rio, M, Sinclair, A J, Terwindt, G, Uluduz, D, Versijpt, J & Lampl, C 2022, ' European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update ', Journal of Headache and Pain, vol. 23, 67 . https://doi.org/10.1186/s10194-022-01431-x
Sacco, S, Amin, F M, Ashina, M, Bendtsen, L, Deligianni, C I, Gil-Gouveia, R, Katsarava, Z, MaassenVanDenBrink, A, Martelletti, P, Mitsikostas, D D, Ornello, R, Reuter, U, Sanchez-del-Rio, M, Sinclair, A J, Terwindt, G, Uluduz, D, Versijpt, J & Lampl, C 2022, ' European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update ', Journal of Headache and Pain, vol. 23, 67 . https://doi.org/10.1186/s10194-022-01431-x
Background A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized controlled trials (RCTs) and real-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f3c8f2847d2637f385e9e10c8f21d8
http://hdl.handle.net/1887/3497503
http://hdl.handle.net/1887/3497503
Autor:
Yan Dong, Margarita Sanchez del Rio, Leslie Citrome, Antje Tockhorn-Heidenreich, Virginia L. Stauffer, Russell M Nichols, Shonda A. Foster
Publikováno v:
Advances in Therapy
Introduction Subcutaneous galcanezumab was an effective, well-tolerated preventive treatment for adults with episodic (EM) or chronic migraine (CM) in 4 phase 3 randomized controlled trials: EVOLVE-1, EVOLVE-2, REGAIN, and CONQUER. Number needed to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c66d6cfcd505331de16056f27189ec
http://europepmc.org/articles/PMC8342379
http://europepmc.org/articles/PMC8342379
Publikováno v:
Expert Review of Clinical Pharmacology. 13:641-654
Cluster headache (CH) is the most common trigeminal autonomic cephalalgia with a significant need for novel treatment options. While the use of most of the acute CH medications is supported by clinical trials and based on a pathophysiological concept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6268ae8f5bb32584445c2cdac2bdba5b
https://doi.org/10.1080/17512433.2020.1774361
https://doi.org/10.1080/17512433.2020.1774361